0
13
Journal Articles about Antipsychotics Showing 181-200 of 931
Reviews and Overviews | April 01, 2001
Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials
Miranda Chakos, M.D.; Jeffrey Lieberman, M.D.; Elaine Hoffman, Ph.D.; Daniel Bradford, M.D.; Brian Sheitman, M.D.
The American Journal of Psychiatry. 2001 April ; 4(158):518-526
PDFPDF
Article | April 01, 2001
An MRI Study of Basal Ganglia Volumes in First-Episode Schizophrenia Patients Treated With Risperidone
Donna J. Lang, B.Sc.; Lili C. Kopala, M.D.; Robert A. Vandorpe, M.D.; Qing Rui, M.B.; Geoffrey N. Smith, Ph.D.; Vina M. Goghari; William G. Honer, M.D.
The American Journal of Psychiatry. 2001 April ; 4(158):625-631
PDFPDF
Brief Report | April 01, 2001
Effect of Clozapine on Caudate Nucleus Volume in Relation to Symptoms of Schizophrenia
Floortje E. Scheepers, M.D.; Christine C. Gispen de Wied, M.D., Ph.D.; Hilleke E. Hulshoff Pol, Ph.D.; René S. Kahn, M.D., Ph.D.
The American Journal of Psychiatry. 2001 April ; 4(158):644-646
PDFPDF
Reviews and Overviews | March 01, 2001
Does Fast Dissociation From the Dopamine D2 Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis
Shitij Kapur, M.D., Ph.D., F.R.C.P.C.; Philip Seeman, M.D., Ph.D., F.R.S.(C.)
The American Journal of Psychiatry. 2001 March ; 3(158):360-369
PDFPDF
Reviews and Overviews | February 01, 2001
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Philip D. Harvey, Ph.D.; Richard S.E. Keefe, Ph.D.
The American Journal of Psychiatry. 2001 February ; 2(158):176-184
PDFPDF
Article | February 01, 2001
Rehospitalization Rates of Chronically Ill Schizophrenic Patients Discharged on a Regimen of Risperidone, Olanzapine, or Conventional Antipsychotics
Jonathan Rabinowitz, Ph.D.; Pesach Lichtenberg, M.D.; Zeev Kaplan, M.D.; Mordechai Mark, M.D.; Danielle Nahon, M.A.; Michael Davidson, M.D.
The American Journal of Psychiatry. 2001 February ; 2(158):266-269
PDFPDF
Brief Report | February 01, 2001
Increased Dopamine D2 Receptor Occupancy and Elevated Prolactin Level Associated With Addition of Haloperidol to Clozapine
Shitij Kapur, M.D., Ph.D., F.R.C.P.C.; Paul Roy, M.D., F.R.C.P.C.; Jeff Daskalakis, M.D., F.R.C.P.C.; Gary Remington, M.D., Ph.D., F.R.C.P.C.; Robert Zipursky, M.D., F.R.C.P.C.
The American Journal of Psychiatry. 2001 February ; 2(158):311-314
PDFPDF
Article | January 01, 2001
Stability of Olfactory Identification Deficits in Neuroleptic-Naive Patients With First-Episode Psychosis
Warrick J. Brewer, Ph.D.; Christos Pantelis, M.B.B.S., M.R.C.Psych., F.R.A.N.Z.C.P.; Vicki Anderson, Ph.D.; Dennis Velakoulis, M.B.B.S., M.Med., F.R.A.N.Z.C.P.; Bruce Singh, M.B.B.S., Ph.D., F.R.A.N.Z.C.P.; David L. Copolov, M.B.B.S., Ph.D., F.R.A.N.Z.C.P., F.R.A.C.P.; Patrick D. McGorry, M.B.B.S., Ph.D., F.R.A.N.Z.C.P.
The American Journal of Psychiatry. 2001 January ; 1(158):107-115
PDFPDF
Brief Report | January 01, 2001
A Novel Augmentation Strategy for Treating Resistant Major Depression
Richard C. Shelton, M.D.; Gary D. Tollefson, M.D., Ph.D.; Mauricio Tohen, M.D., Dr.P.H.; Stephen Stahl, M.D.; Kimberley S. Gannon, Ph.D.; Thomas G. Jacobs, M.S.; William R. Buras, B.Sc.; Frank P. Bymaster, M.Sc.; Wei Zhang, M.D., Ph.D.; Kimberley A. Spencer, B.Sc.; Peter D. Feldman, Ph.D.; Herbert Y. Meltzer, M.D.
The American Journal of Psychiatry. 2001 January ; 1(158):131-134
PDFPDF
Article | November 01, 2000
Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in Schizophrenia
Tony P. George, M.D.; Douglas M. Ziedonis, M.D., M.P.H.; Alan Feingold, Ph.D.; W. Thomas Pepper, B.A.; Cheryl A. Satterburg, M.S.W.; Justin Winkel, B.A.; Bruce J. Rounsaville, M.D.; Thomas R. Kosten, M.D.
The American Journal of Psychiatry. 2000 November ; 11(157):1835-1842
PDFPDF
Reviews and Overviews | September 01, 2000
Depression in Schizophrenia: Perspective in the Era of “Atypical” Antipsychotic Agents
Samuel G. Siris, M.D.
The American Journal of Psychiatry. 2000 September ; 9(157):1379-1389
PDFPDF
Images in Psychiatry | September 01, 2000
The Token Economy
Robert Paul Liberman,, M.D.
The American Journal of Psychiatry. 2000 September ; 9(157):1398-1398
PDFPDF
Article | September 01, 2000
Differentiating Primary From Secondary Negative Symptoms in Schizophrenia: A Study of Neuroleptic-Naive Patients Before and After Treatment
Victor Peralta, M.D.; Manuel J. Cuesta, M.D.; Alfredo Martinez-Larrea, M.D.; Jose F. Serrano, M.D.
The American Journal of Psychiatry. 2000 September ; 9(157):1461-1466
PDFPDF
Brief Report | August 01, 2000
Heat Intolerance in Patients With Chronic Schizophrenia Maintained With Antipsychotic Drugs
Haggai Hermesh, M.D.; Roni Shiloh, M.D.; Yoram Epstein, Ph.D.; Hillel Manaim, M.D.; Abraham Weizman, M.D.; Hanan Munitz, M.B., B.S., M.R.C.Psych.
The American Journal of Psychiatry. 2000 August ; 8(157):1327-1329
PDFPDF
Regular Article | July 01, 2000
Low Incidence of Persistent Tardive Dyskinesia in Elderly Patients With Dementia Treated With Risperidone
Dilip V. Jeste , M.D.; Akiko Okamoto , Sc.D.; Judy Napolitano , R.N.; John M. Kane , M.D.; Rick A. Martinez , M.D.
The American Journal of Psychiatry. 2000 July ; 7(157):1150-1155
PDFPDF
Article | June 01, 2000
Differential Efficacy of Olanzapine for Deficit and Nondeficit Negative Symptoms in Schizophrenia
Alex Kopelowicz, M.D.; Roberto Zarate, Ph.D.; Konstantinos Tripodis, M.D.; Veronica Gonzalez, B.A.; Jim Mintz, Ph.D.
The American Journal of Psychiatry. 2000 June ; 6(157):987-993
PDFPDF
Article | June 01, 2000
Relation of Familial Schizophrenia to Negative Symptoms But Not to the Deficit Syndrome
Dolores Malaspina, M.D.; Raymond R. Goetz, Ph.D.; Scott Yale, M.S.W.; Ariela Berman, B.S.; Jill Harkavy Friedman, Ph.D.; Fabien Tremeau, M.D.; David Printz, M.D.; Xavier Amador, Ph.D.; Janet Johnson, M.D.; Alan Brown, M.D.; Jack M. Gorman, M.D.
The American Journal of Psychiatry. 2000 June ; 6(157):994-1003
PDFPDF
Brief Report | June 01, 2000
Decreased Serotonin 2A Receptor Densities in Neuroleptic-Naive Patients With Schizophrenia: A PET Study Using [18F]Setoperone
Elton T.C. Ngan, M.D., F.R.C.P.C.; Lakshmi N. Yatham, M.D.; Thomas J. Ruth, Ph.D.; Peter F. Liddle, B.M.B.Ch., Ph.D., F.R.C.P.C.
The American Journal of Psychiatry. 2000 June ; 6(157):1016-1018
PDFPDF
Brief Report | June 01, 2000
Subjective Experience and Striatal Dopamine D2 Receptor Occupancy in Patients With Schizophrenia Stabilized by Olanzapine or Risperidone
Lieuwe de Haan, M.D.; Jules Lavalaye, M.D.; Don Linszen, M.D., Ph.D.; Peter M.A.J. Dingemans, Ph.D.; Jan Booij, M.D., Ph.D.
The American Journal of Psychiatry. 2000 June ; 6(157):1019-1020
PDFPDF
Article | May 01, 2000
Normal P50 Suppression in Schizophrenia Patients Treated With Atypical Antipsychotic Medications
Gregory A. Light, B.A.; Mark A. Geyer, Ph.D.; Brett A. Clementz, Ph.D.; Kristin S. Cadenhead, M.D.; David L. Braff, M.D.
The American Journal of Psychiatry. 2000 May ; 5(157):767-771
PDFPDF
Copyright ©
American
Psychiatric
Association